These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 600941)

  • 61. [The blood donorship and post-transfusion hepatitis (author's transl)].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1979 May; 118(18):554-6. PubMed ID: 455382
    [No Abstract]   [Full Text] [Related]  

  • 62. [Frequency of detecting HBsAg among pregnant women living in different regions of the Soviet Union].
    Mikhaĭlov MI; Ivankin AA; Fomichenko NI; Zubov SV; Zhavoronok SV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):64-6. PubMed ID: 4036411
    [No Abstract]   [Full Text] [Related]  

  • 63. Prevention of type B hepatitis.
    Hoofnagle JH
    Gastroenterology; 1979 Jun; 76(6):183-5. PubMed ID: 437452
    [No Abstract]   [Full Text] [Related]  

  • 64. Distribution of ad and ay subtypes of hepatitis B surface antigen among hepatitis patients and symptomless carriers in Hungary.
    Halmosdi G; Perkedi J; Valló D
    Infection; 1976; 4(2):51-2. PubMed ID: 61943
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Viral hepatitis morbidity in blood recipients].
    Grinshteĭn EA; Aleĭnik MD; Klimova NIa; Makarevich IK; Karavashkina EV
    Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):16-9. PubMed ID: 7279883
    [No Abstract]   [Full Text] [Related]  

  • 66. [Incidence of the hepatitis B antigen carrier state in tuberculosis patients and its differential diagnostic significance].
    Shtefanaru LK; Tsybuliak SN; Busygina RN; Kozhoka GG; Grigorian VG
    Vopr Virusol; 1982; 27(2):247-50. PubMed ID: 7046251
    [No Abstract]   [Full Text] [Related]  

  • 67. [Independence of the appearance of HBsAg in the saliva and blood serum].
    Nimadava P; Tsatsral Kh; Oiuunbileg Zh; Anan'ev VA; Dolgor M
    Vopr Virusol; 1988; 33(2):173-5. PubMed ID: 3414066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Province of origin of hepatitis B surface antigen carriers among blood donors in Port Moresby.
    Iga T; Babona DV; Nurse GT
    Asia Pac J Public Health; 1989; 3(3):237-41. PubMed ID: 2620026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biochemical evaluation of ultrafiltrate in dialysis-dependent HBsAG-positive patients.
    Andrew R; Hariharan S; Saha V; John JT; Kirubakaran MG; Shastry JC
    Nephron; 1988; 49(1):88. PubMed ID: 3380225
    [No Abstract]   [Full Text] [Related]  

  • 70. [A case of fulminant hepatitis developing in a HBsAG carrier after chemotherapy of malignant lymphoma].
    Hanta T; Okita K; Matsuda S; Konishi T; Yasunaga M; Kado Y; Nawata H; Ogino M; Shingai Y; Fukumoto Y
    Nihon Shokakibyo Gakkai Zasshi; 1984 Apr; 81(4):1089-93. PubMed ID: 6748319
    [No Abstract]   [Full Text] [Related]  

  • 71. [HBs-antigen specific suppressor cells in asymptomatic HBs-antigen carriers].
    Ishimaru H; Watanabe K; Matsuda T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1219-24. PubMed ID: 2959809
    [No Abstract]   [Full Text] [Related]  

  • 72. [Studies on the HBV carriers who became seronegative during the follow-up].
    Tamura I; Shimase K; Ichimura H; Kaneto E; Kurimura O; Tsuchie H; Kurimura T
    Kansenshogaku Zasshi; 1985 Feb; 59(2):65-9. PubMed ID: 3925039
    [No Abstract]   [Full Text] [Related]  

  • 73. Humoral immune response in Hepatitis B virus infections.
    Vranckx R
    Infection; 1983; 11(2):114-7. PubMed ID: 6862635
    [No Abstract]   [Full Text] [Related]  

  • 74. Prevalence of hepatitis B surface antigen in northern Nigerian blood donors.
    Kulkarni AG; Aloowooja FO; Wayo GB
    Vox Sang; 1986; 50(3):151-3. PubMed ID: 3716288
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Detection of Australia antigen in unpaid donors].
    Marder VL; Balabaniuk IV; Polis NE; Gorobets IuF
    Voen Med Zh; 1979 Apr; (4):45-6. PubMed ID: 473624
    [No Abstract]   [Full Text] [Related]  

  • 76. Incidence of hepatitis B antigen among Jordanian volunteer blood donors.
    Awidi AS; Tarawneh MS; el-Khateeb M; Hijazi S; Shahrouri M
    Public Health; 1984 Mar; 98(2):92-6. PubMed ID: 6718675
    [No Abstract]   [Full Text] [Related]  

  • 77. The labelling of galactose residues in hepatitis B surface antigen glycoprotein.
    Skelly J; Howard CR; Zuckerman AJ
    J Gen Virol; 1978 Dec; 41(3):447-57. PubMed ID: 745007
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Characteristics of the formation of the immunologic response to hepatitis B virus in patients with leukemia].
    Golosova TV; Faĭnshteĭn FE; Pobedinskaia IN; Liubimova LS
    Gematol Transfuziol; 1985 Nov; 30(11):21-4. PubMed ID: 4085767
    [No Abstract]   [Full Text] [Related]  

  • 79. [Carriage of the hepatitis B virus surface antigen as one of the unfavorable prognostic factors in breast cancer].
    Mamedov MK; Mikhaĭlov MI
    Vopr Virusol; 1992; 37(1):71. PubMed ID: 1413719
    [No Abstract]   [Full Text] [Related]  

  • 80. Chronic carriage of hepatitis B surface antigen following acute hepatitis B infection.
    Milne A
    J Infect; 1984 Sep; 9(2):203-4. PubMed ID: 6501908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.